ロード中…
Gene Promoter-Methylation Signature as Biomarker to Predict Cisplatin-Radiotherapy Sensitivity in Locally Advanced Cervical Cancer
Despite efforts to promote health policies focused on screening and early detection, cervical cancer continues to be one of the leading causes of mortality in women; in 2020, estimated 30,000 deaths in Latin America were reported for this type of tumor. While the therapies used to treat cervical can...
主要な著者: | , , , , , , , , , , , |
---|---|
フォーマット: | Online 論文 テキスト |
言語: | English |
出版事項: |
Frontiers Media S.A.
2022
|
主題: | |
オンライン・アクセス: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963763/ https://www.ncbi.nlm.nih.gov/pubmed/35359376 http://dx.doi.org/10.3389/fonc.2022.773438 |